NCAPH and neoplasm: Additionally, we observed that NCAPH-KD combined with these inhibitors resulted in a substantial reduction in the expression of NCAPH, E2F1, and Ki67 in the xenografted tumor tissues when compared to single treatments with Eve or Flav (Figure 6G).